Greek
English
Market Access
Pricing Bulletins
Pricing Bulletins
2021 - Pricing Bulletins
2020 - Pricing Bulletins
2019 - Pricing Bulletins
2018 - Pricing Bulletins
Correction – Supplementary Price Bulletin for Human Use due to voluntary price reductions 06.06.2018
2017 - Pricing Bulletins
2016 - Pricing Bulletins
2015 - Pricing Bulletins
2014 - Pricing Bulletins
2013 - Pricing Bulletins
2012 - Pricing Bulletins
2011 - Pricing Bulletins
2010 - Pricing Bulletins
2009 - Pricing Bulletins
2008 - Pricing Bulletins
2007 - Pricing Bulletins
2006 - Pricing Bulletins
2005 - Pricing Bulletins
2004 - Pricing Bulletins
2003 - Pricing Bulletins
2002 - Pricing Bulletins
2001 - Pricing Bulletins
2000 - Pricing Bulletins
1999 - Pricing Bulletins
1998 - Pricing Bulletins
1997 - Pricing Bulletins
1996 - Pricing Bulletins
1995 - Pricing Bulletins
1994 - Pricing Bulletins
Pricing Determination
Draft Law re: “Regulation of matters relating to the National Health System, pharmaceuticals, pharmacies, and other provisions”-Translation
by karkanis
22.11.2011 – New Ministerial Decision “Provisions of pricing of medicinal products”-Translation
by karkanis
21.06.2011 – Observations of SFEE on the draft ministerial decision on pricing of medicinal products
by karkanis
16.05.2011 – Ministerial Decision regarding new wholesale margin and abolishment of discounts
by karkanis
Announcement by the Secretariat General of Commerce – Pharmaceutical Products under Law 3816/2010
by karkanis
01.09.2010 – Translation of Market Decree 8/2010 – SUBJECT: “Amendment of articles 334,336, 340 and 342 of Chapter 27 “MEDICINES” of Market Decree 7/2009 as in force”
by karkanis
05.08.2010 – Amendment of articles 331, 333 of Chapter “MEDICINES” of Market Decree 7/2009 as in force – Market Decree No7
by karkanis
06.04.2010 – Translation of the Letter sent to the Minister of Economy, Competitiveness and Shipping
by karkanis
Amendment of certain articles of Chapter 27 “Medicines” of the Market Decree 7/09 & 8/09 (Translation of Market Decree No. 2)
by karkanis
16.02.2010 – Translation of Press Release by the Ministry of Economy about the Medicinal Products Price Determination Policy
by karkanis
Reimbursement
Ministerial Decision No. DYG3 (a)/oik.104744 entitled: Implementation of a reference pricing system for drawing up, revising and supplementing the list of reimbursed pharmaceutical products”
by karkanis
E-prescription
Claw back – Rebate
Hospital Debts / EOPYY
31.05.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 714.5 mio
by zoe.magklara
28.02.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 611.7 mio
by zoe.magklara
31.01.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 576.2 mio
by zoe.magklara
31.5.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.050 mil.
by karkanis
30.4.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.020 mil.
by karkanis
31.3.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈1,050 mil.
by karkanis
28.2.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈1,070 mil.
by karkanis
31.1.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€995mil.
by karkanis
31.12.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€970 mil.
by karkanis
30.11.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.050 bil.
by karkanis
31.10.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.150 bil.
by karkanis
30.9.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1bil.200 mil.
by karkanis
31.8.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.200 mil.
by karkanis
30.6.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.390 bil.
by karkanis
31.5.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.470 bil.
by karkanis
Regarding the off-setting of the rebate amount due (9% & volume) by pharmaceutical companies with hospital debts
by karkanis
ΟJ 262/A/16.12.2011 – Off-setting of the entry ticket and the 2011 rebate – Inofficial translation
by karkanis
9.6.2010 – Joint Press Release by the Ministry of Finance and the Ministry of Health & Public Solidarity regarding the settlement of hospital debts
by karkanis
10.5.2010 – Translation of the Letter sent to Mr. Elias Plaskovitis, Secretary General of the Ministry of Finance, President of the Committee of Hospital Debts and to Mr. Nikolaos Polyzos, Secretary General of the Ministry of Health and Social Solidarity
by karkanis
March 13, 2009 – SFEE’s informative Letter addressed to the Directors General of SFEE Member Companies regarding Hospital Debts
by karkanis
EOF Topics
Following SFEE's BoD decision, SFEE's SPCs mini-site set to offline status due to EOF's corresponding e-platform.
We would like to inform you that at the following link you are leaving SFEE’s site and redirect to EOF’s site.
Via Menu ‘Human’>Search you can find information re pharmaceutical products by choosing the Product name, Active Ingredients, ATC or Company
Subsequently, from the browser you can find the requested information.
In the documentation section you will find online the Summary of Product Characteristics (SPC) and the Patient Leaflet (PL), and if there is the link of Public Assessment Report
EOPYY
Pharmacovigilance
EC Regulation on implementation of the Pharmacovigilance legislation published in the OJEU
by karkanis
Amended process for electronic reporting of adverse reactions to the National Organization for Medicines (EOF)
by karkanis
CMDh GUIDANCE DOCUMENT FOR DECLARATION FORM SUBMISSION DDPS (DETAILED DESCRIPTION PHARMACOVIGILANCE SYSTEM) ALREADY APPROVED BY A COMPETENT AUTHORITY (CA) of the EEA (including Iceland, Norway, Liechtenstein and the EMA)
by karkanis
The rules governing Medicinal Products in the European Union Volume 10 – Guidance Documents applying to Clinical Trials
by karkanis
PhVWP and CMD(h) Best Practice Guide for Work Sharing concerning the assessment of PSURs of products for which an EU harmonised virtual birth date and related harmonised data lock point have been agreed
by karkanis